RecruitingNot ApplicableNCT06897553

ACT for Mental Health in Neurological Disorders

Acceptance and Commitment Therapy- Based Group Therapy for Mental Health in Neurological Disorders


Sponsor

Bielefeld University

Enrollment

44 participants

Start Date

Dec 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to examine the efficacy of this manual for mental health in people with mixed neurological disorders, including post-COVID. These conditions are often associated with cognitive impairment, which may hamper the effects of psychoterapy. Executive functioning and especially the ability to abstract thinking may be useful for individuals using Acceptance and Commitment Therapy. Therefore, the main questions research questions are: * Is this intervention effective in improving mental health? * Do executive functions predict the extent of social participation and mental health at the end of therapy? Participants will take part in 8 weekly group therapy sessions of 100 minutes each.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a type of psychological therapy called Acceptance and Commitment Therapy (ACT) for people with neurological disorders (such as Parkinson's disease, multiple sclerosis, or stroke) who are also experiencing depression, anxiety, or significant stress. ACT focuses on helping people accept difficult emotions and commit to living in line with their personal values, rather than fighting against unwanted feelings. Researchers want to know if ACT can meaningfully improve mental health and quality of life in this population. **You may be eligible if...** - You have a neurological disorder and are experiencing significant symptoms of depression, anxiety, or stress (scoring above standard cut-offs on the DASS-21 questionnaire) - You have sufficient thinking and communication ability to participate in therapy sessions - You are motivated to engage in psychological therapy **You may NOT be eligible if...** - You have significant behavioral problems such as severe irritability or apathy - You have dementia, psychosis, a personality disorder, or intellectual disability - You are currently receiving another form of psychotherapy or neuropsychological therapy - You have a level of impairment that would prevent meaningful participation Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALACT-based group therapy

ACT-based group therapy based on the manual "Living Well with Neurological Conditions" published by Hill et al. (2017; NHS Fundation Trust; available: https://goo.gl/aX6qB5). The manual was translated into German and adapted by shortening sessions, simplifying language and adapting exercises based on clinical experience. The publication of the feasibility study for the adapted manual is currently in preparation. The group therapy includes eight weekly sessions with a duration of 100 minutes each. Three to six individuals participate in a group. The therapy is delivered by at least one licensed psychotherapists. A co-therapist might be included based on individual needs of the group members.


Locations(1)

Neuropsychologische Hochschulambulanz Bielefeld

Bielefeld, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06897553


Related Trials